LOVASTATIN (MEVINOLIN) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A MULTICENTER STUDY

被引：238
作者：
HAVEL, RJ
HUNNINGHAKE, DB
ILLINGWORTH, DR
LEES, RS
STEIN, EA
TOBERT, JA
BACON, SR
BOLOGNESE, JA
FROST, PH
LAMKIN, GE
LEES, AM
LEON, AS
GARDNER, K
JOHNSON, G
MELLIES, MJ
RHYMER, PA
TUN, P
机构：
[1] MERCK SHARP & DOHME RES LABS, DEPT CLIN RES, RAHWAY, NJ 07065 USA
[2] UNIV CALIF SAN FRANCISCO, SCH MED, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA
[3] UNIV MINNESOTA, LIPID RES CLIN, MINNEAPOLIS, MN 55455 USA
[4] OREGON HLTH SCI UNIV, DEPT MED, CLIN NUTR & LIPID METAB CLIN, PORTLAND, OR 97201 USA
[5] NEW ENGLAND DEACONESS HOSP, PERIPHERAL VASC DIS SECT INTERNAL MED, BOSTON, MA 02215 USA
[6] UNIV CINCINNATI HOSP, MED CTR, DEPT PATHOL & LAB MED, CINCINNATI, OH USA
来源：
ANNALS OF INTERNAL MEDICINE | 1987年 / 107卷 / 05期
关键词：
D O I：
10.7326/0003-4819-107-5-609
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：609 / 615
页数：7
相关论文
共 28 条
[1]   MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
[2]   MEVINOLIN AND COLESTIPOL STIMULATE RECEPTOR-MEDIATED CLEARANCE OF LOW-DENSITY LIPOPROTEIN FROM PLASMA IN FAMILIAL HYPERCHOLESTEROLEMIA HETEROZYGOTES [J].
BILHEIMER, DW ;
GRUNDY, SM ;
BROWN, MS ;
GOLDSTEIN, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (13) :4124-4128
[3]   METABOLIC STUDIES IN FAMILIAL HYPERCHOLESTEROLEMIA - EVIDENCE FOR A GENE-DOSAGE EFFECT INVIVO [J].
BILHEIMER, DW ;
STONE, NJ ;
GRUNDY, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) :524-533
[4]  
BROWN MS, 1985, PHARMACOL BASIS THER, P827
[5]   SERUM AND LIPOPROTEIN APOLIPOPROTEIN-B LEVELS IN NORMAL SUBJECTS AND PATIENTS WITH HYPERLIPOPROTEINEMIA [J].
DURRINGTON, PN ;
BOLTON, CH ;
HARTOG, M .
CLINICA CHIMICA ACTA, 1978, 82 (1-2) :151-160
[6]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7]  
GOLDSTEIN JL, 1983, METABOLIC BASIS INHE, P672
[8]  
GRUNDY SM, 1985, J LIPID RES, V26, P1464
[9]   LIPOPROTEIN-CHOLESTEROL DISTRIBUTIONS IN SELECTED NORTH-AMERICAN POPULATIONS - LIPID RESEARCH CLINICS PROGRAM PREVALENCE STUDY [J].
HEISS, G ;
TAMIR, I ;
DAVIS, CE ;
TYROLER, HA ;
RIFKIND, BM ;
SCHONFELD, G ;
JACOBS, D ;
FRANTZ, ID .
CIRCULATION, 1980, 61 (02) :302-315
[10]   EFFECTIVENESS OF MEVINOLIN ON PLASMA-LIPOPROTEIN CONCENTRATIONS IN TYPE-II HYPERLIPOPROTEINEMIA [J].
HOEG, JM ;
MAHER, MB ;
ZECH, LA ;
BAILEY, KR ;
GREGG, RE ;
LACKNER, KJ ;
FOJO, SS ;
ANCHORS, MA ;
BOJANOVSKI, M ;
SPRECHER, DL ;
BREWER, HB .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (11) :933-939
123